Structure Database (LMSD)

LM_ID Common Name Systematic Name Main class Sub class Mass Formula
LMFA04010122 17-F4t-NeuroP (4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010511 17-J4-NeuroP (4Z,7Z)-9-((1S,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010443 17-epi-17-A4-NeuroP (4Z,7Z)-9-((1R,2R)-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopent-3-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010243 17-epi-17-D4c-NeuroP (4Z,7Z)-9-((1R,2S,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010246 17-epi-17-D4t-NeuroP (4Z,7Z)-9-((1S,2R,5S)-5-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-3-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010371 17-epi-17-E4c-NeuroP (4Z,7Z)-9-((1R,2S,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010374 17-epi-17-E4t-NeuroP (4Z,7Z)-9-((1S,2R,3R)-3-hydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-5-oxocyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010115 17-epi-17-F4c-NeuroP (4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010118 17-epi-17-F4t-NeuroP (4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)cyclopentyl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010507 17-epi-17-J4-NeuroP (4Z,7Z)-9-((1S,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010455 20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2R)-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010263 20-D4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010266 20-D4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,5S)-5-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010391 20-E4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010394 20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010527 20-F3t-NeuroP-DPAn-3 12-((1S,2R,3R,5S)-3,5-dihydroxy-3S-hydroxy-1E-penten-1-yl)cyclopentyl)-dodeca-7Z,10Z-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 380.26 C22H36O5
LMFA04010001 20-F4-NeuroP (4Z,7Z,10Z)-12-(3,5-dihydroxy-2-((E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010135 20-F4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010138 20-F4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((S,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010519 20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010451 20-epi-20-A4-NeuroP (4Z,7Z,10Z)-12-((1R,2R)-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopent-3-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010259 20-epi-20-D4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010262 20-epi-20-D4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,5S)-5-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-3-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010387 20-epi-20-E4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010390 20-epi-20-E4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3R)-3-hydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)-5-oxocyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010526 20-epi-20-F3t-NeuroP-DPAn-3 12-((1S,2R,3R,5S)-3,5-dihydroxy-3R-hydroxy-1E-penten-1-yl)cyclopentyl)-dodeca-7Z,10Z-dienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 380.26 C22H36O5
LMFA04010131 20-epi-20-F4c-NeuroP (4Z,7Z,10Z)-12-((1R,2S,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010134 20-epi-20-F4t-NeuroP (4Z,7Z,10Z)-12-((1S,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxypent-1-en-1-yl)cyclopentyl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010515 20-epi-20-J4-NeuroP (4Z,7Z,10Z)-12-((1S,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010421 4,11-diepi-11-A4-NeuroP 3-((1S,2R)-2-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopent-3-en-1-yl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010193 4,11-diepi-11-D4c-NeuroP 3-((1S,2S,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010192 4,11-diepi-11-D4t-NeuroP 3-((1R,2R,5R)-5-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-3-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010321 4,11-diepi-11-E4c-NeuroP 3-((1S,2S,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010320 4,11-diepi-11-E4t-NeuroP 3-((1R,2R,3S)-3-hydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-5-oxocyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010065 4,11-diepi-11-F4c-NeuroP 3-((1S,2S,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010064 4,11-diepi-11-F4t-NeuroP 3-((1R,2R,3S,5R)-3,5-dihydroxy-2-((S,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)cyclopentyl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010485 4,11-diepi-11-J4-NeuroP 3-((1R,5S)-5-((R,1E,5Z,8E,11Z)-3-hydroxytetradeca-1,5,8,11-tetraen-1-yl)-4-oxocyclopent-2-en-1-yl)propanoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010397 4,7-diepi-4-A4-NeuroP (R,E)-4-hydroxy-6-((1S,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010145 4,7-diepi-4-D4c-NeuroP (R,E)-4-hydroxy-6-((1S,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010144 4,7-diepi-4-D4t-NeuroP (R,E)-4-hydroxy-6-((1R,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010273 4,7-diepi-4-E4c-NeuroP (R,E)-4-hydroxy-6-((1S,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010272 4,7-diepi-4-E4t-NeuroP (R,E)-4-hydroxy-6-((1R,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010017 4,7-diepi-4-F4c-NeuroP (R,E)-6-((1S,2S,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010016 4,7-diepi-4-F4t-NeuroP (R,E)-6-((1R,2R,3R,5S)-3,5-dihydroxy-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)-4-hydroxyhex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 378.24 C22H34O5
LMFA04010461 4,7-diepi-4-J4-NeuroP (R,E)-4-hydroxy-6-((1R,5S)-4-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-2-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010399 4-A4-NeuroP (S,E)-4-hydroxy-6-((1R,5R)-2-oxo-5-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopent-3-en-1-yl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 358.21 C22H30O4
LMFA04010151 4-D4c-NeuroP (S,E)-4-hydroxy-6-((1R,2S,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010154 4-D4t-NeuroP (S,E)-4-hydroxy-6-((1S,2R,5S)-5-hydroxy-3-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010279 4-E4c-NeuroP (S,E)-4-hydroxy-6-((1R,2S,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5
LMFA04010282 4-E4t-NeuroP (S,E)-4-hydroxy-6-((1S,2R,3R)-3-hydroxy-5-oxo-2-((2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl)cyclopentyl)hex-5-enoic acid Docosanoids [FA04] Neuroprostanes [FA0401] 376.22 C22H32O5